Optimum Strategic Communications Hosts 14th Annual Healthcare Investor Conference

World-class speakers from the biotech and healthcare industry and the investment community

How to survive and thrive in tough markets

LONDON, October 4, 2022 /PRNewswire/ — Optimal strategic communications (Optimum), the international strategic consulting firm in health communication, will welcome its 14th Annual Healthcare Investor Conference Thursday, October 6, 2022 in person at the Wellcome Collection, London.

Amid growing uncertainty and volatility in public markets, Optimum is once again bringing together industry and investment experts to share their views and perspectives on the current shape of the healthcare sector and its future prospects. As one of the key events on the European life science investment calendar, Optimum’s conference provides a unique platform to discuss and debate the issues most relevant to the sector, with particular emphasis this year on the outlook for public and private markets.

Commenting on the event, Mary ClarkCEO of Optimum Strategic Communications, said:

“Our conference is once again bringing together companies and investors to discuss and debate critical issues and trends affecting our industry. After a boom in the biotechnology sector in response to COVID-19, we have now entered a period of uncertainty, with volatile public markets threatening to impact biotechnology investments As the industry faces new challenges, we welcome the opportunity to hear from leaders in their fields, those who have a unparalleled experience and perspective and who are uniquely positioned to share ideas and information on what it takes to build a successful biotech business and how to access solid capital.”



Mary ClarkCEO, Optimum Strategic Communications

Can private markets continue to drive the development of life sciences?

Chair: Stephen Hansen, BioCentury

Roel BulthuisCapital of Inkef

hakan gokerM-Ventures

Karin KleinmanMRL Venture Capital Funds

Soren Møller, Novo Holdings

Billions of dollars have been raised by venture capital funds and invested in the life sciences industry in recent years, but can this be sustained with more volatile global markets coupled with high inflation?

Chat by the fire with Mike Ward and Werner Lanthaler

Mike Ward, Clarivate

Werner LanthalerEvotec

Building a successful biotech has never been easy. One of the industry’s best-known entrepreneurs shares the secrets of his success.

Financing growth: walking a tightrope

Chair: Hannah KuchlerFinancialTimes

Olivia CavlanAlchemab Therapeutic

Andrea PontiGHO Capital

Gil Bar NahoumJefferies

Tom BurtSofinnova Partners

With public markets increasingly difficult to navigate, what sources of capital are available to fund growth and what do you need to do to access them? Our panel will share their views on how best to navigate this critical phase of business development.

Global investment in health: can hindsight sharpen the crystal ball for the future?

Chair: Amy Brownassess the benefit

Dan MahonyEvotec

Gareth PowellPolar Capital

Dan Mahony and Gareth Powellfounders of Polar Capital’s Healthcare fund, examine their crystal ball and discuss biotech innovation – what got us where we are and what lies ahead?

Spotlight on Optimum’s featured charity: Best For You, NHS

Chris ChaneyCEO of CW+, presents the groundbreaking work of Best For You, a purpose-built and user-led mental health service for young people around the world. North West London health region. the best for you provides a radical new day service for 11-25 year olds that integrates the best of in-person support from the NHS, third sector and local government with a digital offer.

Detailed agenda and registration details are available on the 14th Annual Healthcare Investor Conference website, here.

If you would like to receive conference panel summaries or speak with the Optimum team, please email [email protected]

About Optimum Strategic Communications

Optimum Strategic Communications is an international health communications consulting firm specializing in strategic investor relations, corporate and financial communications. Our senior team of healthcare specialists, based in London, amsterdam, stockholm, Zürichand New Yorkare experienced and trusted advisors to some of the world’s most exciting public and private companies, large and small, in pharmaceutical, biotechnology, medical, health technology, health services and industrial biotechnology.

Over the past 25 years, our team has worked with over 300 companies in the healthcare sector, advising them on financial communication and investor relations, including major corporate activities such as fundraising, IPOs, mergers and acquisitions, as well as corporate reputation and stress scenarios.

We have an exceptional network of contacts within the international investment community in Europe and the United States; contacts that we have built and maintained over the past three decades. The Optimum team includes former fund managers and analysts, as well as financial and corporate communications specialists.

For more information, please visit

SOURCE Optimal Strategic Communications